These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9703909)
21. GM3 as a novel growth regulator for human gliomas. Noll EN; Lin J; Nakatsuji Y; Miller RH; Black PM Exp Neurol; 2001 Apr; 168(2):300-9. PubMed ID: 11259118 [TBL] [Abstract][Full Text] [Related]
22. Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro. Knüpfer MM; Pulzer F; Schindler I; Hernaíz Driever P; Knüpfer H; Keller E Anticancer Res; 2001; 21(1A):347-51. PubMed ID: 11299760 [TBL] [Abstract][Full Text] [Related]
23. [Antitumor efficacy of FK 973 on malignant glioma cells]. Shimizu K; Yamada M; Mabuchi E; Matsui Y; Tamura K; Moriuchi S; Park K; Mogami H Gan To Kagaku Ryoho; 1989 Jul; 16(7):2367-72. PubMed ID: 2751317 [TBL] [Abstract][Full Text] [Related]
24. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
25. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies. Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290 [TBL] [Abstract][Full Text] [Related]
26. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. Dhandapani KM; Mahesh VB; Brann DW J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214 [TBL] [Abstract][Full Text] [Related]
27. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250 [TBL] [Abstract][Full Text] [Related]
28. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres. Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693 [TBL] [Abstract][Full Text] [Related]
29. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949 [TBL] [Abstract][Full Text] [Related]
30. [Effects of cisplatin on cultured glioma cells]. Honda C; Tabuchi K Gan To Kagaku Ryoho; 1986 May; 13(5):1921-6. PubMed ID: 3707152 [TBL] [Abstract][Full Text] [Related]
31. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand. Gourdeau H; McAlpine JB; Ranger M; Simard B; Berger F; Beaudry F; Farnet CM; Falardeau P Cancer Chemother Pharmacol; 2008 May; 61(6):911-21. PubMed ID: 17622531 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells. Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177 [TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats]. Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921 [TBL] [Abstract][Full Text] [Related]
34. Selective enrichment of hypericin in malignant glioma: pioneering in vivo results. Noell S; Mayer D; Strauss WS; Tatagiba MS; Ritz R Int J Oncol; 2011 May; 38(5):1343-8. PubMed ID: 21399870 [TBL] [Abstract][Full Text] [Related]
35. Undersulfation of glycosaminoglycans induced by sodium chlorate treatment affects the progression of C6 rat glioma, in-vivo. Lobão-Soares B; Alvarez-Silva M; Mendes de Aguiar CB; Nicolau M; Trentin AG Brain Res; 2007 Feb; 1131(1):29-36. PubMed ID: 17174944 [TBL] [Abstract][Full Text] [Related]
36. [Proliferation inhibition of glioma cells by vitamin K2]. Sun L; Yoshii Y; Miyagi K; Ishida A No Shinkei Geka; 1999 Feb; 27(2):119-25. PubMed ID: 10065443 [TBL] [Abstract][Full Text] [Related]
37. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Sliwa M; Markovic D; Gabrusiewicz K; Synowitz M; Glass R; Zawadzka M; Wesolowska A; Kettenmann H; Kaminska B Brain; 2007 Feb; 130(Pt 2):476-89. PubMed ID: 17107968 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic analysis of in vitro and in vivo brain tumor models. Schuster JM; Friedman HS; Bigner DD Neurol Clin; 1991 May; 9(2):375-82. PubMed ID: 1944106 [TBL] [Abstract][Full Text] [Related]
39. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo. Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946 [TBL] [Abstract][Full Text] [Related]
40. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents. Yang JJ; Yin JH; Yang DI Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]